NYU Winthrop Hospital Internal Medicine Residency Program;
NYU Winthrop Hospital;
Mineola;
NY;
USA;
The University of Queensland School of Medicine;
Ochsner Clinical School;
New Orleans;
LA;
USA;
Ochsner Medical Oncology Fellowship Program;
Ochsner Clinic Foundation;
New Orleans;
LA;
USA;
Louisiana State University School of Public Health;
New Orleans;
LA;
USA;
Ochsner Cancer Institute;
Ochsner Clinic Foundation;
New Orleans;
LA;
USA;
Clinical; Marker; PD-1; Inhibitor; Immunotherapy; Nivolumab; Pembrolizumab;